Patients with ESRD under hemodiylisis. speckle echo
Conditions
Interventions
Intervention group: we do this study with L-Carnitine oral solution with dosage of 1000 mg right after each session of hemodialysis which prescribe for 3 months.the manufactor company is Bonyan Salama
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Left ventricular ejection fraction more than or equal of 50 persent 3 times a weak routine and regular hemodialysis Agreement to take part in the study Hemodialysis patient with age more than 18 who start hemodialysis for more than 3 months If the pateint have been used L-Carnetine supplement before the study,should stop using it for at least 1 weak for entrance to our study
Exclusion criteria
Exclusion criteria: Pateint who used medicine which make drug intractions with the supplement Pateints who are pregnant or have Liver Failure , Thyroid dysfunction, Nephrotic syndrome,Cancers, Vasculitis or other inflamatory disease Disagreement to take part in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ejection fraction is define with the ability of left venticle to pump blood in each haert beat and bring up with percent. Timepoint: Ejection fraction measure in the begining of study and the after 3months of recivining L-Carnitine supplements. Method of measurement: Speckle tracking echocardiography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMina Keshtkar
Shiraz University of Medical Sciences
Outcome results
None listed